in the short and vertical long axes were computed and displayed. I-123 MIBG analysis: The tomograms were divided into nine segments for semiqualitative interpretation. Two short-axis slices (one each from the apex and base) were each divided into four evenly spaced regions. The apex was interpreted using the vertical long-axis view ( Figure 1 ). For semiquantitative assessment, the images were scored by the visual estimation of the extent of the MIBG defect in each of the nine segments, using a scale ranging from 0 (normal uptake) to 3 (no uptake). Total MIBG defect scores were generated by summing the scores of the nine segments for each patient. Thallium-201 myocardial scintigraphy: In eight patients, myocardial imaging using 2mCi of T1-201 chroride was performed at rest. Scintigrams were obtained and analyzed as MIBG myocardial scintigraphy. Holter 24-hour ECG: All patients underwent Holter 24-hour electrocardiography (ECG). Holter recording and analysis were performed using a DMC-4100 system (Nihon Kohden, Tokyo, Japan). Percentages of the ventricular (V) pacing beat to the 24-hour beats were calculated to determine the V pacing rate. Ultrasonic echocardiography:
All patients underwent ultrasonic echocardiographic studies using SSD-9000 (ALOKA, Tokyo, Japan) and the left ventricular ejection fraction (LVEF) was evaluated in each patient by the method of Teichholtz.
Jpn Heart J September 1995 Representative images of a patient in the VVI group are shown in Figure 4 . There is no visible cardiac uptake and the total MIBG defect score was calculated as 27 (A). T1 myocardial scintigraphy revealed low uptake in the distal site of the anterior wall, posterior wall, proximal site of the posterior wall and a defect in the apex. The total T1 defect score was calculated as 7 (B).
DISCUSSION
In this study, patients with an implanted permanent pacemaker showed various degrees of reduction in left ventricular MIGB activity. This reduction was more prominent in the VVI than the DDD group. In this limited study of eight patients, thallium scintigraphic abnormalities were observed in three patients. However, the MIBG scintigraphic abnormalities were greater than the T1 scintigraphic abnormalities.
The mechanism for the reduction in MIBG activity in patients with implanted permanent pacemakers was not evaluated in this study. T1 scintigraphic abnormalities have been reported mainly in the posteroseptal, posteroinferior, and apical regions in patients with a permanent pacemaker.8) Defects detected by T1 scintigraphy can express either reduced perfusion or a disturbance of the T1-201 uptake process. In this study, MIBG scintigraphic defects were observed even in the normal perfusion segments of T1. The mechanism of MIBG scintigraphic abnormalities may differ from that of T1 scintigraphy.
MIBG is a guanethidine analogue originally described by Wieland et al.9) In 1981, a study revealed that MIBG is a norepinephrine storage analogue1), and another documented normal MIBG cardiac imaging in humans.10)
The explanation of MIBG scintigraphic abnormalities is only speculative. One possible explanation is related to the increased sympathetic nervous system activity during ventricular pacing. This activity has been reported to increase more in patients with a VVI than DDD pacemaker. Maintenance of atrioventricular synchrony during DDD pacing has been associated with lower levels of cardiac sympathetic activity. Increased sympathetic activity in patients with a VVI pacemaker may result in the down-regulation of cardiac sympathetic nervous system activity.
Cardiac pacing is well-established in the management of patients with severe disorders of impulse initiation and transmission in the cardiac conduction system. The prognosis and quality of life are markedly improved in most patients .
However, 12-31% of patients suffer sudden death within months or years of pacemaker implantation.11-13) DDD pacing has been shown to possess comparative hemodynamic advantages over VVI pacing, and patient survival is significantly better with DDD pacing, regardless of the indications for pacing.14,15) In with an implanted pacemaker also may be related to sudden cardiac death.
Study limitations:
In this study, the underlying arrhythmias differed between the two groups and four patients with diabetes mellitus were included. Although MIBG scintigraphic abnormalities in patients with diabetes mellitus have been reported, the same number of patients with this condition were included in each group and no patient manifested autonomic neuropathy. Therefore, we believe that the differences in the total MIBG defect scores between the two groups reflect a true difference between the pacing modes. However, the examination of more patients will be needed to confirm these preliminary observations.
CONCLUSION
MIBG scintigraphic abnormalities were seen in patients with an implanted permanent pacemaker and these abnormalities were more prominent with the VVI than DDD pacemaker.
